These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10705283)

  • 1. [Ski and SnoN: antagonistic proteins of TGFbeta signaling].
    Vignais ML
    Bull Cancer; 2000 Feb; 87(2):135-7. PubMed ID: 10705283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of Ski/SnoN protein in the regulation of TGF-beta signal pathway].
    Lu ZH; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):233-6. PubMed ID: 12905729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts.
    Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
    Arthritis Rheum; 2007 May; 56(5):1694-705. PubMed ID: 17469184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ski and SnoN: negative regulators of TGF-beta signaling.
    Luo K
    Curr Opin Genet Dev; 2004 Feb; 14(1):65-70. PubMed ID: 15108807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
    Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
    J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
    Edmiston JS; Yeudall WA; Chung TD; Lebman DA
    Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
    Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
    Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of Ski and SnoN co-repressors by anisomycin.
    Vázquez-Macías A; Ruíz-Mendoza AB; Fonseca-Sánchez MA; Briones-Orta MA; Macías-Silva M
    FEBS Lett; 2005 Jul; 579(17):3701-6. PubMed ID: 15967445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SnoN co-repressor binds and represses smad7 gene promoter.
    Briones-Orta MA; Sosa-Garrocho M; Moreno-Alvarez P; Fonseca-Sánchez MA; Macías-Silva M
    Biochem Biophys Res Commun; 2006 Mar; 341(3):889-94. PubMed ID: 16442497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
    He J; Tegen SB; Krawitz AR; Martin GS; Luo K
    J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma.
    Boone B; Haspeslagh M; Brochez L
    J Dermatol Sci; 2009 Jan; 53(1):26-33. PubMed ID: 18782659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling.
    Reed JA; Bales E; Xu W; Okan NA; Bandyopadhyay D; Medrano EE
    Cancer Res; 2001 Nov; 61(22):8074-8. PubMed ID: 11719430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SKI activates Wnt/beta-catenin signaling in human melanoma.
    Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
    Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
    Mori Y; Chen SJ; Varga J
    Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
    Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
    J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular dynamics of Smad-mediated TGFbeta signaling.
    Greene RM; Nugent P; Mukhopadhyay P; Warner DR; Pisano MM
    J Cell Physiol; 2003 Nov; 197(2):261-71. PubMed ID: 14502566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas.
    Zhang F; Lundin M; Ristimäki A; Heikkilä P; Lundin J; Isola J; Joensuu H; Laiho M
    Cancer Res; 2003 Aug; 63(16):5005-10. PubMed ID: 12941827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of TGFbeta in human cancers.
    Wong SF; Lai LC
    Pathology; 2001 Feb; 33(1):85-92. PubMed ID: 11280615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus.
    Villanacci V; Bellone G; Battaglia E; Rossi E; Carbone A; Prati A; Verna C; Niola P; Morelli A; Grassini M; Bassotti G
    Hum Pathol; 2008 Mar; 39(3):403-9. PubMed ID: 18261624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.